Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called plasma cells, which are types of white blood ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

Multiple myeloma is a rare haematologic malignancy, representing about 1–2% of all cancers and 17% of haematologic malignancies in the US, predominantly affecting older adults and more common in ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

After finishing this test you will receive a FREE snapshot report with a summary evaluation and graph. You will then have the option to purchase the full results for $6.95 This test is intended ...

证券之星消息，智翔金泰(688443)01月27日在投资者关系平台上答复投资者关心的问题。 投资者：请问gr1802的目前进度以及后面的预期，两个突破性药物gr1803和gr2001有没有BD的考虑 智翔金泰董秘：尊敬的投资者您好，公司GR1802注射液的多个适应症均处于临床试验阶段 ...